Health Economics

Health economics is concerned with issues of efficiency, effectiveness, value, health behaviours and the functioning of healthcare systems. We need a health system which provides the best services not because those who can shout the loudest insist on them but because they are high-value, fair, equitable, transparent and evidence-based. Australia has no shortage of pressing public health problems and we need to get spending right on healthcare if we are to meet future population needs.

Our Health Economics team is led by Associate Professor Louisa Gordon. Our research is focused on economic evaluations and decision-modelling of healthcare interventions that span a range of health conditions and populations but has a key theme around cancer control strategies, from prevention through to survivorship care.

Economic evaluations in health care assess the costs and patient benefits of new services and technologies to determine their value for money. This usually involves both short-term ‘within-trial’ analyses and long-term decision-analytic modelling. Ultimately, this work assists in the translation of interventional research into clinical practice so that effective services also demonstrate good economic value. The team also undertakes work that highlights areas of inefficiency where healthcare resources are misused or could be more efficiently delivered. Finally we recognise that initiatives which promote the prevention of disease is paramount to preserving a sustainable health system, and view economics around this work as a priority.


  • Roadmap Options for Melanoma Screening in Australia (Melanoma-ROSA)
  • Health economic research for melanoma and keratinocyte skin cancers (QSKIN)
  • Economic modelling of the harms and benefits of sun exposure (SUNEX)
  • The IC3 Trial: Identifying Cirrhosis and Liver Cancer in Primary Care
  • Ovarian cancer: investigating Variation in care and survival, Aetiology and Risk factors to Improve outcomes in Australia via National data linkage. The OVARIAN study
  • Evaluation of a decision support intervention for men with early stage prostate cancer
  • Economic evaluation of a telehealth delivered psychosocial support for patients with brain tumours
  • Economics of organ transplantation and skin cancers
  • Economic impacts of regulation to limit indoor tanning behaviours and prevent skin cancers
  • Blood cancers
  • Brain cancer
  • Breast cancer
  • Colorectal cancer
  • Lung cancer
  • Melanoma
  • Non-melanoma skin cancers Keratinocytic skin cancers
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Neuroendocrine
  • Liver


  • Thomas Elliott, Health Economist
  • Daniel Lindsay, Senior Research Officer
  • Doreen Nabulaku, Research assistant / PhD Student
  • Jason Zischke, PhD Student
  • Ming Ho, PhD Student / Surgeon

Internal Collaborators

External Collaborators

  • Dr Gary Jeffrey, The University of Western Australia, Gastroenterologist/Hepatologist
  • Dr Leon Adam, The University of Western Australia, Gastroenterologist/Hepatologist
  • Dr Martin Eden, The University of Manchester, England
  • Craig Sinclair, Cancer Council Victoria
  • Professor Jon Karnon, Flinders University, Adelaide
  • Professor Ian Reid, The University of Auckland, Auckland NZ
  • Professor Ann Webb, The University of Manchester, England
  • Associate Professor Penelope Schofield, University of Swinburne, Melbourne.
  • Dr Katharina Merollini, University of Sunshine Coast, Sunshine Coast.
  • Professor Raymond Chan, Flinders University, Adelaide
  • Professor Monika Janda, Queensland University of Technology, Brisbane.
  • Professor Sandi Hayes, Queensland University of Technology, Brisbane.
  • Cancer Council Queensland
  • Cancer Australia


No Student Projects